Navigation Links
LSUHSC research identifies enzyme that makes survival molecule for key vision cells
Date:6/26/2009

New Orleans, LA Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, identifying an enzyme that makes neuroprotectin D1 which specifically and selectively protects retinal cells key for vision, will be published in the June 26, 2009 issue of the Journal of Biological Chemistry.

Dr. Bazan's research team previously discovered neuroprotectin D1 (NPD1), a naturally produced chemical messenger that protects cells from injury caused by free radicals and other oxidative stress. Neuroprotectin D1 is derived from the omega-3 fatty acid, DHA (docosahexaenoic acid) which is present in both brain and retinal cells.

Retinal pigment epithelial (RPE) cells are essential for the survival of rod and cone photoreceptor cells. RPE cells regulate the renewal of the tips of photoreceptor cells among other functions. When RPE cells do not function properly, photoreceptor cells are damaged and can die, leading to decreased vision and eventual blindness as in such conditions as retinitis pigmentosa and age-related macular degeneration. A number of stressors, including free radicals, damage RPE cells. Dr. Bazan's lab has shown that RPE cells produce NPD1 in response to oxidative stress. The focus of this research project was to further define that process.

The LSUHSC team's main participant was Jorgelina Calandria, a PhD student in the LSUHSC Neuroscience Center Graduate Program working with Dr. Bazan, along with Pranab Mukherjee, PhD, Research Assistant Professor. Calandria developed a stable cell line to explore the role of an enzyme called 15-LOX-1 that they believed might play a key role in the process of converting DHA into NPD1. They designed a series of experiments using cells with, and those deficient in, 15-LOX-1, and measured response to oxidative stress. They found that the cells deficient in 15-LOX-1 were more vulnerable and susceptible to cell death and that NPD1 production in those cells was also diminished, demonstrating that 15-LOX-1 is key to the production of NPD1. The team also conducted experiments where retinal cells deficient in 15-LOX-1 were treated with NPD1. NPD1 was able to selectively and successfully rescue them, demonstrating the protective power of NPD1 in RPE cells.

"These studies have created a new interest in RPE cells not only due to the potential applications in the treatment of retinal degenerative diseases, but also in neurodegenerative diseases such as Parkinson's disease," notes Dr. Bazan. "This research has helped us define NPD1 survival bioactivity in the RPE cell. It is clinically significant because it underpins the exploration of therapeutic interventions for diseases affecting millions."

According to Research to Prevent Blindness, an estimated 1.75 million Americans over age 40 have decreased vision from Age-related Macular Degeneration. That number is expected to increase to 3 million by 2020.

The National Institutes of Health estimates that at least 500,000 people in the US currently have Parkinson's disease, although some estimates are much higher. The risk of Parkinson's disease increases with age, so the impact of this disease is expected to increase as the population ages.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. LSUHSC research finds single gene controls growth of some cancers
2. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
3. LSUHSC dental researcher funded to develop better dental materials
4. LSUHSC research shows fish oil protects against diseases like Parkinsons
5. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
6. LSUHSCs England leads development of new testing guidelines for common nerve disorder
7. LSUHSCs Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer
8. LSUHSCs Fontham makes history
9. LSUHSC public health contributes to estimate of HPV-related cancers
10. LSUHSC awarded grant to address nursing shortage
11. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
Breaking Medicine Technology: